Microbiology and Immunology

You are here

Publications

Found 272 results

Author Title Type [ Year

]

Filters: First Letter Of Last Name is C [Clear All Filters]

1996

Wolff G, Mastrangeli A, Heinflink M, Falck-Pedersen E, Gershengorn MC, Crystal RG. 1996. Ectopic expression of thyrotropin releasing hormone (TRH) receptors in liver modulates organ function to regulate blood glucose by TRH.. Nat Genet. 12(3):274-9.

Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G. 1996. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells.. J Exp Med. 183(1):147-57.

Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G. 1996. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells.. J Exp Med. 183(1):147-57.

Mastrangeli A, Harvey BG, Yao J, Wolff G, Kovesdi I, Crystal RG, Falck-Pedersen E. 1996. "Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype.. Hum Gene Ther. 7(1):79-87.

1997

Mack CA, Song WR, Carpenter H, Wickham TJ, Kovesdi I, Harvey BG, Magovern CJ, Isom OW, Rosengart T, Falck-Pedersen E et al.. 1997. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.. Hum Gene Ther. 8(1):99-109.

Mack CA, Song WR, Carpenter H, Wickham TJ, Kovesdi I, Harvey BG, Magovern CJ, Isom OW, Rosengart T, Falck-Pedersen E et al.. 1997. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.. Hum Gene Ther. 8(1):99-109.

Abrahamsen K, Kong HL, Mastrangeli A, Brough D, Lizonova A, Crystal RG, Falck-Pedersen E. 1997. Construction of an adenovirus type 7a E1A- vector.. J Virol. 71(11):8946-51.

Worgall S, Wolff G, Falck-Pedersen E, Crystal RG. 1997. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.. Hum Gene Ther. 8(1):37-44.

Ehrt S, Shiloh MU, Ruan J, Choi M, Gunzburg S, Nathan C, Xie Q, Riley LW. 1997. A novel antioxidant gene from Mycobacterium tuberculosis.. J Exp Med. 186(11):1885-96.

Elkon KB, Liu CC, Gall JG, Trevejo J, Marino MW, Abrahamsen KA, Song X, Zhou JL, Old LJ, Crystal RG et al.. 1997. Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors.. Proc Natl Acad Sci U S A. 94(18):9814-9.

1998

Orth P, Cordes F, Schnappinger D, Hillen W, Saenger W, Hinrichs W. 1998. Conformational changes of the Tet repressor induced by tetracycline trapping.. J Mol Biol. 279(2):439-47.

Gall JG, Crystal RG, Falck-Pedersen E. 1998. Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype.. J Virol. 72(12):10260-4.

Karp CL, Wysocka M, Ma X, Marovich M, Factor RE, Nutman T, Armant M, Wahl L, Cuomo P, Trinchieri G. 1998. Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance.. Eur J Immunol. 28(10):3128-36.

Kapitskaya MZ, Dittmer NT, Deitsch KW, Cho WL, Taylor DG, Leff T, Raikhel AS. 1998. Three isoforms of a hepatocyte nuclear factor-4 transcription factor with tissue- and stage-specific expression in the adult mosquito.. J Biol Chem. 273(45):29801-10.

Coughlin CM, Salhany KE, Gee MS, LaTemple DC, Kotenko S, Ma X, Gri G, Wysocka M, Kim JE, Liu L et al.. 1998. Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.. Immunity. 9(1):25-34.

1999

Pardoux C, Ma X, Gobert S, Pellegrini S, Mayeux P, Gay F, Trinchieri G, Chouaib S. 1999. Downregulation of interleukin-12 (IL-12) responsiveness in human T cells by transforming growth factor-beta: relationship with IL-12 signaling.. Blood. 93(5):1448-55.

Miyazawa N, Leopold PL, Hackett NR, Ferris B, Worgall S, Falck-Pedersen E, Crystal RG. 1999. Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors.. J Virol. 73(7):6056-65.

Peng Y, Trevejo J, Zhou J, Marino MW, Crystal RG, Falck-Pedersen E, Elkon KB. 1999. Inhibition of tumor necrosis factor alpha by an adenovirus-encoded soluble fusion protein extends transgene expression in the liver and lung.. J Virol. 73(6):5098-109.

Kaner RJ, Worgall S, Leopold PL, Stolze E, Milano E, Hidaka C, Ramalingam R, Hackett NR, Singh R, Bergelson J et al.. 1999. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.. Am J Respir Cell Mol Biol. 20(3):361-70.

Na SY, Kang BY, Chung SW, Han SJ, Ma X, Trinchieri G, Im SY, Lee JW, Kim TS. 1999. Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB.. J Biol Chem. 274(12):7674-80.

Cole-Strauss A, Gamper H, Holloman WK, Muñoz M, Cheng N, Kmiec EB. 1999. Targeted gene repair directed by the chimeric RNA/DNA oligonucleotide in a mammalian cell-free extract.. Nucleic Acids Res. 27(5):1323-30.

Cole-Strauss A, Gamper H, Holloman WK, Muñoz M, Cheng N, Kmiec EB. 1999. Targeted gene repair directed by the chimeric RNA/DNA oligonucleotide in a mammalian cell-free extract.. Nucleic Acids Res. 27(5):1323-30.

2000

Wang IM, Contursi C, Masumi A, Ma X, Trinchieri G, Ozato K. 2000. An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages.. J Immunol. 165(1):271-9.

Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naudé B, Deitsch KW et al.. 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance.. Mol Cell. 6(4):861-71.

2001

Deitsch KW, Carlton JM, Wootton JC, Wellems TE. 2001. Host sequences in Plasmodium falciparum and Plasmodium vivax genomic DNA: horizontal transfer or contamination artifact? FEBS Lett. 491(1-2):164-5.